advertisement
Gazzard G 25
Showing records 1 to 25 | Display all abstracts from Gazzard G107467 Iridotomy to slow progression of visual field loss in angle-closure glaucoma
Rouse B
Cochrane Database of Systematic Reviews 2023; 1: CD012270
108467 Treatment expectations in glaucoma: what matters most to patients?
Safitri A
Eye 2023; 0: 1-9
108097 Clinical risk stratification in glaucoma
Poostchi A
Eye 2023; 0: 1-7
107524 Differentiating stages of functional vision loss from glaucoma using the Disc Damage Likelihood Scale and cup:disc ratio
Philippin H
British Journal of Ophthalmology 2024; 108: 349-356
107840 Five-Year Visual Field Outcomes of the HORIZON Trial
Montesano G
American Journal of Ophthalmology 2023; 251: 143-155
108097 Clinical risk stratification in glaucoma
Kastner A
Eye 2023; 0: 1-7
107840 Five-Year Visual Field Outcomes of the HORIZON Trial
Ometto G
American Journal of Ophthalmology 2023; 251: 143-155
107467 Iridotomy to slow progression of visual field loss in angle-closure glaucoma
Le JT
Cochrane Database of Systematic Reviews 2023; 1: CD012270
108467 Treatment expectations in glaucoma: what matters most to patients?
Konstantakopoulou E
Eye 2023; 0: 1-9
107524 Differentiating stages of functional vision loss from glaucoma using the Disc Damage Likelihood Scale and cup:disc ratio
Matayan EN
British Journal of Ophthalmology 2024; 108: 349-356
107840 Five-Year Visual Field Outcomes of the HORIZON Trial
Ahmed IIK
American Journal of Ophthalmology 2023; 251: 143-155
107524 Differentiating stages of functional vision loss from glaucoma using the Disc Damage Likelihood Scale and cup:disc ratio
Knoll KM
British Journal of Ophthalmology 2024; 108: 349-356
108097 Clinical risk stratification in glaucoma
Konstantakopoulou E
Eye 2023; 0: 1-7
107467 Iridotomy to slow progression of visual field loss in angle-closure glaucoma
Gazzard G
Cochrane Database of Systematic Reviews 2023; 1: CD012270
108467 Treatment expectations in glaucoma: what matters most to patients?
Hu K
Eye 2023; 0: 1-9
107840 Five-Year Visual Field Outcomes of the HORIZON Trial
Ramulu PY
American Journal of Ophthalmology 2023; 251: 143-155
108467 Treatment expectations in glaucoma: what matters most to patients?
Gazzard G
Eye 2023; 0: 1-9
107524 Differentiating stages of functional vision loss from glaucoma using the Disc Damage Likelihood Scale and cup:disc ratio
Macha E
British Journal of Ophthalmology 2024; 108: 349-356
108097 Clinical risk stratification in glaucoma
Gazzard G
Eye 2023; 0: 1-7
107524 Differentiating stages of functional vision loss from glaucoma using the Disc Damage Likelihood Scale and cup:disc ratio
Mbishi S
British Journal of Ophthalmology 2024; 108: 349-356
108097 Clinical risk stratification in glaucoma
Jayaram H
Eye 2023; 0: 1-7
107840 Five-Year Visual Field Outcomes of the HORIZON Trial
Chang DF; Crabb DP
American Journal of Ophthalmology 2023; 251: 143-155
107524 Differentiating stages of functional vision loss from glaucoma using the Disc Damage Likelihood Scale and cup:disc ratio
Makupa A
British Journal of Ophthalmology 2024; 108: 349-356
107840 Five-Year Visual Field Outcomes of the HORIZON Trial
Gazzard G
American Journal of Ophthalmology 2023; 251: 143-155
107524 Differentiating stages of functional vision loss from glaucoma using the Disc Damage Likelihood Scale and cup:disc ratio
Matsinhe CD; da Gama IV; Monjane MJ; Ncheda JA; Mulobuana FAF; Muna E; Guylene NF; Gazzard G; Marques AP; Shah P; Macleod D; Makupa W; Burton MJ
British Journal of Ophthalmology 2024; 108: 349-356
